Cell Surface Marker Detection Market Report 2025

The cell surface marker detection market size has grown strongly in recent years. It will grow from $5.91 billion in 2024 to $6.44 billion in 2025 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to expansion in biomedical research, evolution of high-content screening, increased chronic disease prevalence, shift towards immunotherapy.

The cell surface marker detection market size is expected to see rapid growth in the next few years. It will grow to $9.9 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to market expansion in emerging economies, expanding biopharmaceutical sector, adoption of single-cell analysis, rise in chronic and infectious diseases, increasing funding for life sciences research. Major trends in the forecast period include advancements in biotechnology, product innovations, technological innovations in flow cytometry, rising prevalence of chronic diseases.

The increasing prevalence of oncology diseases is set to drive the growth of the cell surface marker detection market. Oncology, characterized by uncontrolled cell growth and spread, has seen a rise attributed to factors like Western lifestyles, poor dietary habits, pollution, and a lack of exercise. Cell surface marker detection plays a crucial role in predicting patient responses to cancer drugs, aiding in point-of-care decisions. Macmillan Cancer Support's October 2022 estimate indicated 3 million people with cancer in 2020, projected to increase to 5.3 million by 2040. This surge in oncology diseases underlines the demand for cell surface marker detection in the market.

The growth of chronic diseases is anticipated to further propel the cell surface marker detection market. Chronic diseases, persistent medical conditions progressing slowly over time, are on the rise globally. Cell surface marker detection contributes to the diagnosis, monitoring, and treatment of chronic diseases, enabling targeted and personalized care. The World Health Organization's September 2022 data highlighted 41 million deaths annually, with 74% attributed to non-communicable diseases (NCDs) or chronic diseases. The prevalence of chronic diseases, including cardiovascular diseases, cancer, respiratory diseases, and diabetes, is a significant driver for the cell surface marker detection market.

Leading companies in the cell surface marker detection market are investing in advanced technologies, such as innovative fluorescent dyes and antibodies, to enhance multicolour flow cytometry capabilities, thereby improving the accuracy and efficiency of immunological research and diagnostics. Bio-Rad has expanded its StarBright Violet Dye series by adding 29 highly validated antibodies conjugated to various StarBright Violet Dyes, which enhances the detection and analysis of multiple cell surface markers in human and animal studies through multicolour flow cytometry. For instance, in May 2024, Bio-Rad Laboratories, Inc., a US-based company specializing in developing and manufacturing advanced technological products, launched three new StarBright Red Dyes: StarBright Red 715, 775, and 815. This expansion increases their existing portfolio of fluorescent dyes to a total of 32 options across multiple lasers, specifically tailored for conventional and full-spectrum flow cytometry applications. Furthermore, these dyes demonstrate minimal background interference compared to traditional cyanine tandem dyes and are stable enough to be fixed in formalin or alcohol-based fixatives without compromising signal integrity.

Innovations in analysis systems, such as imaging analysis systems, provide a competitive edge in the cell surface marker detection market. CytoSMART Technologies BV's launch of CytoSMART Omni FL in April 2022 is an example of this trend. This fluorescence live-cell imaging analysis system, featuring a high-resolution CMOS camera, enables the observation of dynamic cellular processes. Used in various fields, including stem cell biology and immuno-oncology, such technologies contribute to advancing research capabilities and strengthening market competitiveness.

In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for $2.8 billion. This acquisition is intended to bolster Thermo Fisher Scientific's specialty diagnostics portfolio by improving innovative solutions for blood cancer diagnostics, with a focus on the early diagnosis and effective treatment of multiple myeloma. The Binding Site Group, based in the UK, specializes in researching, developing, manufacturing, and distributing tests for detecting cancers and immune disorders, including flow cytometry.

Major companies operating in the cell surface marker detection market are Thermo Fisher Scientific Inc., Beckman Coulter Inc., Siemens Healthineers, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Sartorius, Becton Dickinson and Company, BD Biosciences, Grifols SA, Applied Microarrays Inc., R&D Systems, Agilent Inc., Sigma-Aldrich, Qiagen NV, Sysmex Corporation, Nihon Kohden Corporation, Abnova Corporation, Diasorin SpA, Janssen Diagnostics, Abcam PLC, GenScript Biotech, BioLegend, Cell Signaling Technology Inc., Merck KGaA, Bio-Techne Corporation, Affymetrix, Danaher Corporation, Zymo Research Corporation, Miltenyi Biotec.

North America was the largest region in the cell surface marker detection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell surface marker detection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell surface marker detection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cell surface marker detection involves the classification of cells based on their markers, which are proteins expressed on the cell surface or carbohydrates linked to the cell membrane. These markers serve as unique identifiers for specific cell types, akin to fingerprints. This process is valuable for categorizing cells based on their distinct markers.

The primary products associated with cell surface marker detection include flow cytometry, hematology analyzers, and various reagents and kits. Flow cytometry is a laboratory test that analyzes the properties of cells or particles suspended in fluid. During the procedure, a sample is injected into a flow cytometer machine, and a computer can rapidly evaluate and process a large number of cells. Flow cytometry is commonly used to assess bone marrow, peripheral blood, and other bodily fluids, playing a crucial role in disease diagnosis, diseases identification, drug discovery research, and cytological academic research. These products are utilized by a range of entities, including pharmaceutical and biotechnology companies, hospitals and clinical testing laboratories, academic and research institutes, among others. They contribute significantly to advancements in medical research, diagnostics, and drug development.

The cell surface marker detection market research report is one of a series of new reports that provides cell surface marker detection market statistics, including cell surface marker detection industry global market size, regional shares, competitors with a cell surface marker detection market share, detailed cell surface marker detection market segments, market trends and opportunities, and any further data you may need to thrive in the cell surface marker detection industry. This cell surface marker detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell surface marker detection market consists of revenues earned by entities by providing cell surface marker detection services such as cell analysis, fluorescence-activated cell sorting (FACS) analysis, immunohistochemistry, blood test, Tbnk test. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell surface marker detection market also includes sales of kits, dyes, analyzers equipment which are used in providing cell surface marker detection services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.